ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

Pediatric CCP Controversy Splits Group Leaders; National Consortium Forms; NCAB to Watch Closely

January 14, 1983

Poll Finds Strong Support For Research; Yarbro Leads International Cancer Nurses.

October 6, 2000

Should Be Cut First, DCT Board Says

December 4, 1981

NCI’s Goal To Increase Minority Participation In Trials, Sondik Says

May 5, 1995

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000